Jubilant Pharmova Ltd (JUBLPHARMA) — Announcement | 11 September 2026

11 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Jubilant Pharmova reports USFDA VAI classification for Spokane facility

💡 Investor Takeaway

The VAI status may delay US contract manufacturing revenue streams and requires monitoring of potential regulatory follow-ups.

Jubilant Pharmova disclosed that its US subsidiary Jubilant HollisterStier LLC received a 'Voluntary Action Indicated' classification from the USFDA following an inspection of its Spokane, Washington sterile injectables facility conducted June 8-17, 2026. The company confirmed receipt of the USFDA Establishment Inspection Report on September 10, 2026, noting this regulatory outcome impacts its contract manufacturing operations in the United States.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JUBLPHARMA ✨ Ask AI About This

About Jubilant Pharmova Ltd (JUBLPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹16,840.79 CrP/E: 47.6ROE: 5.0%ROCE: 7.4%Div Yield: 0.47%

View full JUBLPHARMA stock details →

📡 Get AI alerts when JUBLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JUBLPHARMA — Free

💡 Ask AI about this filing

"How will VAI classification affect Jubilant's US contract revenue?""What specific remediation steps does Jubilant plan for Spokane facility?""When will USFDA re-inspect the Spokane facility?"

Ask AI Free →

📊 More JUBLPHARMA filings

Announcement — 29 September 2026Jubilant Pharmova announced that its trading window closes on October 1, 2026, ahead of Q2 results, ...
🔴 Corporate Action — 28 September 2026Jubilant Pharmova sent a specimen letter to shareholders on September 28, 2026, informing them that ...
🔴 Announcement — 1 September 2026Jubilant Pharmova received a GST show cause notice from Mysore tax authorities on August 31, 2026, d...
🔴 Announcement — 28 August 2026Jubilant Pharmova disclosed receipt of a GST show cause notice from the Joint Commissioner of CGST, ...
🟡 Board Meeting — 26 August 2026Jubilant Pharmova held its 48th AGM on August 26, 2026, via video conference, passing all resolution...

See all JUBLPHARMA filings →

🔥 Also filed on 11 September 2026

MONEYBOXXMoneyboxx Finance LtdInsider Trading ADANIPORTSAdani Ports & Special Economic Zone LtdAnnouncement 517170Edvenswa Enterprises LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement SIGMAADVSigma Advanced System LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JUBLPHARMA files new disclosures

Track JUBLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.